2020
DOI: 10.1056/nejmp2030033
|View full text |Cite
|
Sign up to set email alerts
|

Trustworthiness before Trust — Covid-19 Vaccine Trials and the Black Community

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
172
1
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 190 publications
(181 citation statements)
references
References 1 publication
5
172
1
3
Order By: Relevance
“…Persistent issues of trust in the modern medical system among these groups speaks to a larger trend in perceptions of healthcare among minority groups in the U.S., which may drive individuals to seek alternative or complimentary medicine, or to neglect health concerns altogether. 19-21 This trust gap, which stems in part from long-term issues of systemic biases in health research and healthcare delivery 22,23 , will have important implications for the adoption and roll-out of a novel coronavirus vaccine.…”
Section: Discussionmentioning
confidence: 99%
“…Persistent issues of trust in the modern medical system among these groups speaks to a larger trend in perceptions of healthcare among minority groups in the U.S., which may drive individuals to seek alternative or complimentary medicine, or to neglect health concerns altogether. 19-21 This trust gap, which stems in part from long-term issues of systemic biases in health research and healthcare delivery 22,23 , will have important implications for the adoption and roll-out of a novel coronavirus vaccine.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, as a major constituent of the cultural and political "system," healthcare must figure out how to become trustworthy and anti-racist in the face of the systemic racism laid bare in the time of COVID-19. 78,79 Examining privilege and power are necessary within healthcare and among its practitioners.…”
Section: Conclusion: Next Stepsmentioning
confidence: 99%
“…Researchers should then explain the plans for their trial going forward and solicit participants' consent. To minimize potential confusion and distrust (14), participants should understand the rationale behind the plan and that their prior consent does not obligate them to continue to participate. If researchers intend to continue with a placebo-controlled design, participants can be encouraged to remain in the trial.…”
Section: Disclosure Unblinding Consentmentioning
confidence: 99%